1. Home
  2. FBIO vs MATH Comparison

FBIO vs MATH Comparison

Compare FBIO & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • MATH
  • Stock Information
  • Founded
  • FBIO 2006
  • MATH 2015
  • Country
  • FBIO United States
  • MATH Hong Kong
  • Employees
  • FBIO N/A
  • MATH N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • MATH Finance/Investors Services
  • Sector
  • FBIO Health Care
  • MATH Finance
  • Exchange
  • FBIO Nasdaq
  • MATH Nasdaq
  • Market Cap
  • FBIO 39.4M
  • MATH 41.1M
  • IPO Year
  • FBIO N/A
  • MATH N/A
  • Fundamental
  • Price
  • FBIO $1.62
  • MATH $2.12
  • Analyst Decision
  • FBIO Strong Buy
  • MATH
  • Analyst Count
  • FBIO 3
  • MATH 0
  • Target Price
  • FBIO $18.00
  • MATH N/A
  • AVG Volume (30 Days)
  • FBIO 277.9K
  • MATH 308.8K
  • Earning Date
  • FBIO 03-27-2025
  • MATH 10-31-2024
  • Dividend Yield
  • FBIO N/A
  • MATH N/A
  • EPS Growth
  • FBIO N/A
  • MATH N/A
  • EPS
  • FBIO N/A
  • MATH 0.17
  • Revenue
  • FBIO $81,501,000.00
  • MATH $31,399,049.00
  • Revenue This Year
  • FBIO N/A
  • MATH N/A
  • Revenue Next Year
  • FBIO $128.63
  • MATH N/A
  • P/E Ratio
  • FBIO N/A
  • MATH $12.71
  • Revenue Growth
  • FBIO 31.51
  • MATH 291.58
  • 52 Week Low
  • FBIO $1.36
  • MATH $0.80
  • 52 Week High
  • FBIO $2.89
  • MATH $2.78
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 33.40
  • MATH 57.93
  • Support Level
  • FBIO $1.65
  • MATH $2.01
  • Resistance Level
  • FBIO $1.85
  • MATH $2.78
  • Average True Range (ATR)
  • FBIO 0.10
  • MATH 0.26
  • MACD
  • FBIO -0.01
  • MATH 0.03
  • Stochastic Oscillator
  • FBIO 7.32
  • MATH 50.30

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

Share on Social Networks: